Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

OTHER(1)
1 unique interventions1 categories

Analytics

Trial Phases

No phase data

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04182763Not ApplicableCompleted
CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN)
Pantothenate Kinase-Associated Neurodegeneration
PrincipalinvestigatorStart date: 2019-12-04
NCT01838018Completed
Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)
Pantothenate Kinase-associated Neurodegeneration (PKAN)
PrincipalinvestigatorStart date: 2013-04-01
NBIAready: Online Collection of Natural History Patient-reported Outcome Measures
Neurodegeneration With Brain Iron Accumulation (NBIA)
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Thomas Klopstock, Prof. Dr.

LMU Klinikum, Friedrich-Baur-Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Neurodegeneration With Brain Iron Accumulation (NBIA)Pantothenate Kinase-Associated Neurodegeneration
Similarity Score30%

Vincent MICHAUD

University Hospital, Bordeaux

Related
1 trials

Shared therapeutic areas:

Neurodegeneration With Brain Iron Accumulation (NBIA)
Similarity Score15%

Elliott Vichinsky, MD

Children's Hospital & Research Center at Oakland Hematology/ Oncology, Pediatric Rehabilitation

Related
1 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration
Similarity Score15%

Patrick Chinnery, MD

Newcastle University Institute of Human Genetics

Related
1 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration
Similarity Score15%

Thomas Klopstock, MD

LMU Klinikum

Related
2 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration
Similarity Score15%

Patricia FERGELOT MAURIN

University Hospital, Bordeaux

Related
1 trials

Shared therapeutic areas:

Neurodegeneration With Brain Iron Accumulation (NBIA)
Similarity Score15%

Fernando Tricta, MD

ApoPharma Inc.

Related
3 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration
Similarity Score15%

Thomas Klopstock, MD

Friedrich-Baur-Institute, Department of Neurology, University of Munich Ziemssenstr

Related
1 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration
Similarity Score15%

Elliott Vichinsky, MD

UCSF Benioff Children's Hospital Oakland

Related
5 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration
Similarity Score15%

Nardo Nardocci, MD

Foundation Neurological Institute C. Besta

Related
1 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04182763Not ApplicablePrincipalInvestigator

CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN)

Pantothenate Kinase-Associated Neurodegeneration
Completed
NCT01838018PrincipalInvestigator

Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)

Pantothenate Kinase-associated Neurodegeneration (PKAN)
Completed
NCT02587858PrincipalInvestigator

NBIAready: Online Collection of Natural History Patient-reported Outcome Measures

Neurodegeneration With Brain Iron Accumulation (NBIA)
Unknown

All 3 trials loaded